-
EP3329909
European procedure
Extract from the Register of European Patents
EP About this file: EP3329909
| EP3329909 - FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME [Right-click to bookmark this link] | Status | Patent revoked Status updated on 12.11.2024 Database last updated on 03.04.2025 | |
| Former | The patent has been granted Status updated on 12.02.2021 | ||
| Former | Grant of patent is intended Status updated on 28.09.2020 | ||
| Former | Examination is in progress Status updated on 08.02.2019 | ||
| Former | Request for examination was made Status updated on 07.12.2018 | ||
| Former | The application has been published Status updated on 04.05.2018 | Most recent event Tooltip | 15.11.2024 | Revocation of patent | published on 18.12.2024 [2024/51] | Applicant(s) | For all designated states Katholieke Universiteit Leuven KU Leuven Research & Development Waaistraat 6 Box 5105 3000 Leuven / BE | For all designated states University Hospital Antwerp Wilrijkstraat 10 2650 Edegem / BE | [2021/11] |
| Former [2018/23] | For all designated states Katholieke Universiteit Leuven KU Leuven Research & Development Waaistraat 6 Box 5105 3000 Leuven / BE | ||
| For all designated states University Hospital Antwerp Wilrijkstraat 10 2650 Edegem / BE | Inventor(s) | 01 /
Ceulemans, Berten Rode Kruislaan 26 2390 Westmalle / BE | 02 /
Lagae, Lieven Boslaan 15A 3050 Oud Heverlee / BE | [2020/44] |
| Former [2018/23] | 01 /
Ceulemans, Berten Rode Kruislaan 26 2390 Westmalle / BE | ||
| 02 /
Lagae, Lieven Boslaan 15A 3050 Oud Heverlee / BE | Representative(s) | Leonard, Thomas Charles Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2021/11] |
| Former [2018/23] | Adamson Jones BioCity Nottingham Pennyfoot Street Nottingham NG1 1GF / GB | Application number, filing date | 18152406.7 | 01.05.2014 | [2018/23] | Priority number, date | US201313887014 | 03.05.2013 Original published format: US201313887014 | [2018/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3329909 | Date: | 06.06.2018 | Language: | EN | [2018/23] | Type: | B1 Patent specification | No.: | EP3329909 | Date: | 17.03.2021 | Language: | EN | [2021/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.04.2018 | Classification | IPC: | A61K31/137, A61P25/08 | [2020/42] | CPC: |
A61K31/5513 (EP,US);
A61K31/135 (EP,US);
A61K31/137 (EP,US);
A61K31/19 (EP,US);
A61K31/36 (EP,US);
A61K31/551 (EP,US);
A61K45/06 (EP,US);
A61P25/08 (EP);
A61P43/00 (EP);
| C-Set: |
A61K31/137, A61K2300/00 (EP,US)
|
| Former IPC [2018/23] | A61K31/137, A61K45/06, A61K31/135, A61K31/19, A61K31/36, A61K31/5513, A61P25/08 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/02] |
| Former [2018/23] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | FENFLURAMINE ZUR VERWENDUNG BEI DER BEHANDLUNG DES DRAVETSYNDROMS | [2018/23] | English: | FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME | [2018/23] | French: | FENFLURAMINE POUR SON UTILISATION DANS LE TRAITEMENT DU SYNDROME DE DRAVET | [2018/23] | Examination procedure | 14.11.2018 | Amendment by applicant (claims and/or description) | 29.11.2018 | Examination requested [2019/02] | 29.11.2018 | Date on which the examining division has become responsible | 12.02.2019 | Despatch of a communication from the examining division (Time limit: M06) | 22.08.2019 | Reply to a communication from the examining division | 25.11.2019 | Despatch of a communication from the examining division (Time limit: M06) | 05.06.2020 | Reply to a communication from the examining division | 28.09.2020 | Communication of intention to grant the patent | 05.02.2021 | Fee for grant paid | 05.02.2021 | Fee for publishing/printing paid | 05.02.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP14724037.8 / EP2991637 | Opposition(s) | Opponent(s) | 01
22.11.2021
20.12.2021
ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | 02
16.12.2021
20.12.2021
ADMISSIBLE TEVA PHARMACEUTICAL INDUSTRIES, LTD. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | [2024/08] |
| Former [2024/04] | |||
| Opponent(s) | 01
22.11.2021
20.12.2021
ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | ||
| 02
16.12.2021
20.12.2021
ADMISSIBLE TEVA PHARMACEUTICAL INDUSTRIES, LTD. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2022/04] | |||
| Opponent(s) | 01
22.11.2021
20.12.2021
ADMISSIBLE Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstr. 2 80538 München / DE Opponent's representative Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstraße 2 80538 München / DE | ||
| 02
16.12.2021
20.12.2021
ADMISSIBLE TEVA PHARMACEUTICAL INDUSTRIES, LTD. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2022/01] | |||
| Opponent(s) | 01
22.11.2021
Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstr. 2 80538 München / DE Opponent's representative Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstraße 2 80538 München / DE | deleted | Deletion: Legal effect of rejection of opposition [ N /P ] | 17.01.2022 | Invitation to proprietor to file observations on the notice of opposition | 27.05.2022 | Reply of patent proprietor to notice(s) of opposition | 15.03.2023 | Date of despatch of rejection of opposition | 01.10.2024 | Legal effect of revocation of patent [2024/51] | 12.11.2024 | Despatch of communication that the patent will be revoked | Appeal following opposition | 31.05.2023 | Appeal received No. T0979/23 | 31.05.2023 | Payment of appeal fee | 17.07.2023 | Statement of grounds filed | 01.10.2024 | Result of appeal procedure: revocation of the patent | 12.11.2024 | Despatch of the decision of the Board of Appeal | 24.05.2023 | Appeal received No. T0979/23 | 24.05.2023 | Payment of appeal fee | 13.07.2023 | Statement of grounds filed | 01.10.2024 | Result of appeal procedure: revocation of the patent | 12.11.2024 | Despatch of the decision of the Board of Appeal | 01.10.2024 | Date of oral proceedings | Fees paid | Renewal fee | 18.01.2018 | Renewal fee patent year 03 | 18.01.2018 | Renewal fee patent year 04 | 25.05.2018 | Renewal fee patent year 05 | 23.05.2019 | Renewal fee patent year 06 | 14.05.2020 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 17.03.2021 | MC | 17.03.2021 | MK | 17.03.2021 | RS | 17.03.2021 | SM | 17.03.2021 | [2024/23] |
| Former [2022/07] | AL | 17.03.2021 | |
| MC | 17.03.2021 | ||
| RS | 17.03.2021 | ||
| SM | 17.03.2021 | ||
| Former [2021/46] | RS | 17.03.2021 | |
| SM | 17.03.2021 | ||
| Former [2021/37] | RS | 17.03.2021 | Documents cited: | Search | [A]JPH05310564 (ADIR); | by applicant | GB1413070 | GB1413078 | EP0441160 | Opposition | EP3329909 | WO2014177676 |